• Welcome to Phoenix Rising!

    Created in 2008, Phoenix Rising is the largest and oldest forum dedicated to furthering the understanding of and finding treatments for complex chronic illnesses such as chronic fatigue syndrome (ME/CFS), fibromyalgia (FM), long COVID, postural orthostatic tachycardia syndrome (POTS), mast cell activation syndrome (MCAS), and allied diseases.

    To become a member, simply click the Register button at the top right.

ME: bitterest row yet in a long saga

patient.journey

Senior Member
Messages
443
http://www.independent.co.uk/news/science/me-bitterest-row-yet-in-a-long-saga-8348389.html

A British psychiatrist should be stripped of an award, fellow scientists said last night, as one of the most heated debates in medical science continued.
Professor Simon Wessely, one of Britain's foremost experts on ME, won the John Maddox Standing up for Science honour earlier this month. The prize was created by the journal Nature and the charitable trust Sense about Science. It was given to Professor Wessely for "courage" in speaking out about his studies into ME in the face a prolonged hate campaign and death threats. The Chinese science writer Fang Shi-min shared the award.
But critics protested against the decision last night. They said the professor's work perpetuates the idea that myalgic encephalomyelitis, also known as chronic fatigue syndrome (CFS), is a mental health problem, trivialising what they claim is a largely physical illness. Malcolm Hooper, emeritus professor of medicinal chemistry at Sunderland University, said: "He's responsible for trying to make ME into a psychiatric condition when it's not. He has done very poor science,,,,
 

Sasha

Fine, thank you
Messages
17,863
Location
UK
http://www.independent.co.uk/news/science/me-bitterest-row-yet-in-a-long-saga-8348389.html

A British psychiatrist should be stripped of an award, fellow scientists said last night, as one of the most heated debates in medical science continued.
Professor Simon Wessely, one of Britain's foremost experts on ME, won the John Maddox Standing up for Science honour earlier this month. The prize was created by the journal Nature and the charitable trust Sense about Science. It was given to Professor Wessely for "courage" in speaking out about his studies into ME in the face a prolonged hate campaign and death threats. The Chinese science writer Fang Shi-min shared the award.
But critics protested against the decision last night. They said the professor's work perpetuates the idea that myalgic encephalomyelitis, also known as chronic fatigue syndrome (CFS), is a mental health problem, trivialising what they claim is a largely physical illness. Malcolm Hooper, emeritus professor of medicinal chemistry at Sunderland University, said: "He's responsible for trying to make ME into a psychiatric condition when it's not. He has done very poor science,,,,

Good to see this. There are some good, calm, factual comments on that piece that are helping us.
 

Firestormm

Senior Member
Messages
5,055
Location
Cornwall England
There are some good, calm, factual comments on that piece that are helping us.

I am not going to pull them out Sasha, but I guess it all depends on your perspective. There are the same misunderstanding of terminology, the same implied quotes meaning something that might not have been meant at events that those re-quoting them were not present etc. etc. etc.

But yes there are some reasoned comments in my opinion also that have appeared so far and don't get into the realms of he-said-she-said/he-meant-didn't-mean hyperbole.

Always nice to see. I wonder how long it will take before word spreads and these are overwhelmed.
 

Firestormm

Senior Member
Messages
5,055
Location
Cornwall England
Couple of comments from Facebook by Dr Charles Shepherd of the ME Association:

I think most people would agree that CBT (and/or counselling) can sometimes help some people to cope with some of the quite significant psychological and social distress that may accompany any long term medical illness. So I do sometimes suggest CBT to patients in these circumstances. However, as has already been pointed out in this discussion, I cannot agree that CBT is the most appropriate form of treatment for ME/CFS when it is based on the model of illness causation where symptoms are perpetuated by (in medical jargon) abnormal illness beliefs and behaviour and consequent deconditioning etc.

Totally agree with this point.

Over the past few weeks I have been working with the Daily Telegraph on a feature that will focus on biomedical research into ME/CFS - partly as a result of some of the recent very negative media coverage given to ME/CFS. We did the photographs for this on Thursday this week and I think it may be published this coming week - possibly tomorrow.

Talk about a coup. Will wait to read with baited breath :)
 

Daisymay

Senior Member
Messages
754
Posted on behalf of Professor Malcom Hooper:

Today the Independent on Sunday has published an interesting article concerning the John Maddox award to Professor Wessely. People will be very grateful to the Independent on Sunday for highlighting this scandal.

http://www.independent.co.uk/news/science/me-bitterest-row-yet-in-a-long-saga-8348389.html

In the article Professor Wessely denies ever having said or written that CFS is all in the mind which is extraordinary given his published record in which he has referred to ME as a belief, as a myth and was involved with a BMJ poll which found ME to be a non-disease best left medically untreated.

Here is a shortened version of Professor Hooper's recent article on Professor Wessely and the John Maddox Prize for people to give to their GP's, hospital consultants and MPs which provides further background information and sets the issue in context:

http://www.meactionuk.org.uk/The-Rewards-of-Science.htm


The rewards of science in the UK


The inaugural John Maddox Prize


On 6th November 2012 it was announced that: “Two strong-minded individuals are the first winners of an award for standing up for science….The prize rewards individuals who have promoted sound science and evidence on a matter of public interest, with an emphasis on those who have faced difficulty or opposition in doing so”. The award is the John Maddox Prize, awarded jointly to British psychiatrist Professor Simon Wessely for his courage in facing opposition to his views about ME and Gulf War Syndrome and to the Chinese science writer Shi-min Fang. The initiative for the prize was shared between the journal Nature and Sense about Science (a charitable trust claiming to change public discussion about science and a sibling of the Science Media Centre, on both of whose Advisory Boards Wessely sits).

The press release referred to “the courage” of the recipients “for communicating sound science and evidence”.



The Problem

There is abundant evidence that Wessely’s views and influence have necessitated extraordinary courage, not by Wessely, but by ME patients in the face of his orchestrated opposition to the acceptance of their disease as a legitimate medical entity despite it having been classified by the World Health Organisation as a neurological disorder since 1969.

Given that Wessely’s belief that ME is a somatoform (ie. behavioural) disorder has been comprehensively invalidated by the scientific evidence, for him to have received a prize for “standing up for science” for his work on ME/CFS has resulted in deserved derision.

World experts have repeatedly shown that Wessely has not produced “sound science and evidence” about ME. Indeed, 21 years ago Peter Behan, Professor of Neurology at Glasgow, showed that the psychiatric hypothesis: “lacked all scientific merit and now, with the emergence of hard data, can be totally rejected” (1).

Psychiatrists of the “Wessely School” are lead advisors on “CFS/ME” to Government Departments and agencies of State. According to them, “CFS/ME” is a “functional somatic syndrome” (ie. a behavioural disorder) in which medically unexplained fatigue is perpetuated by inappropriate illness beliefs, pervasive inactivity, membership of a self-help group and being in receipt of disability benefits (2). They assert that there are no physical signs of disease and there is no pathology causing the patients’ symptoms, and that patients are merely “hypervigilant” to “normal bodily sensations” (3). They insist that CFS/ME should be managed by behavioural interventions including “cognitive re-structuring” (ie. brain washing) and graded exercise therapy to “reverse” patients’ “mis-perceptions”.

They state that they “have decided to treat CFS and ME as if they are one illness” (4), so there can be no doubt that they are referring to ME and not to a separate psychiatric disorder.

Over the last 25 years Wessely has written extensively about “CFS/ME”. He believes that attribution by patients to a virus is somatisation “par excellence” (5); that patients acquire “secondary gain” by “adopting the sick role” such as State and insurance benefits, which he states “may be contingent upon their remaining unwell” (6); he argues that ME is simply a belief that one has an illness called ME and that it is not a real disease but “part of the world of myth” (7); that patients prefer the label “ME” because it is “better for their self-esteem” (
cool.gif
; that symptoms “have no anatomical or physiological basis (9); that no investigations should be performed to confirm the diagnosis (10); that ME “has become a fad” (11); that patients “believe their symptoms are the result of an organic disease process (but) many doctors believe the converse” (12); indeed the Wessely School have advised that the first duty of the doctor is to avoid legitimisation of symptoms (13). In 2002 the British Medical Journal ran a poll of what readers considered “non-diseases” in which Wessely was instrumental: it concluded that, along with big ears and freckles, ME is a “non-disease” best left medically untreated (14).

Wessely trivialises a devastating disorder from which people die: the recent tragic deaths from ME of three young women in the UK, all in their 30s (Sophia Mirza, Lynn Gilderdale and Emily Collingridge) should shame all “non-believers”.

Wessely’s influence also extends to the insurance industry. PRISMA is a multi-national healthcare company working with insurance companies; it arranges “rehabilitation” programmes (ie. graded exercise therapy) for people with ME claiming on their policies. In the PRISMA company information, Simon Wessely was listed as a Corporate Officer and was a member of the Supervisory Board (ie. higher than the Board of Management).

In 1995 the insurance industry complained that it: “stands to lose millions if we do not move quickly to address this increasing problem” (15) and in 2002 said: “Take for instance a 30 year old who succumbed aged 30 when earning £75,000 a year. The policyholder might be in line to get two-thirds salary -- £50,000. Over 35 years, if the condition never resolved, the insurer would be paying out £1.75 million. Re-naming the condition CFS and discarding earlier labels including ME was helpful. ‘Syndrome’ implies a range of causes and symptoms. The company’s exposure to chronic fatigue claims has pushed it into a very proactive approach. We get Prisma to talk to the individual and also to the partner; Prisma will work out a programme. Until recently, the role of IP (income protection) providers stopped at paying claims. Now they are initiating intervention” (16).

Could there be a more clearly expressed reason for Wessely School members who work for the insurance industry to deny that ME/CFS exists and to oppose the evidence that it is a serious organic disease from which full recovery is unlikely?

If objective evidence of organic pathology were to be acknowledged, it would undermine the insurers’ assertion that it is a psychosocial disorder and therefore ineligible for benefit payment.

The “Real” Science

In contrast, Dr Harvey Alter (who discovered the hepatitis C virus), Chief of Clinical Studies and distinguished investigator at the US National Institutes of Health (one of the world’s foremost medical research centres) said in 2010: “I’m absolutely convinced that when you define this disease by proper criteria, this is a very serious and significant medical disease, and not a psychological disease. It has the characteristics of a viral disease” (17)

Professor Luc Montagnier (who in 2008 won the Nobel prize for discovering the AIDS virus and Honorary Member of the European Society for ME) said: “Scientists have already uncovered a lot about ME, but this information does not reach professional healthcare personnel, and the disease is not taken seriously. It is about time this changes” (18).

This is an important point: it is not that accurate information and knowledge are unavailable; it is that in the UK, the evidence is being systematically blocked by the networking of the Wessely School who promote their own views about “CFS/ME”.

World-renowned virus-hunter, Professor Ian Lipkin, Director, Centre for Infection and Immunity, Columbia University, said that patients with ME have a particular pattern of immunoreactivity, indicating a persistent disease process: “Back in the mid to late 1990s…I looked at these patients, many of them coming out of a clinic that was run in the Karolinska, which at that point was one of the best clinics for CFS in the world…..these patients…have some kind of immunological activation…I am convinced, after working in this field for a very long time, that this is a bona fide syndrome”. ME/CFS was described as “this crippling disease” (19). ME/CFS, he said, “is not a psychosomatic disorder” (20) and he viewed it as “a major illness” (21).

The US Food and Drug Administration has confirmed that ME/CFS is “a serious complex disease that lacks treatment and suffers from the unwillingness of the insurance companies” to address it (22).

International experts have shown comprehensively that Wessely’s beliefs about ME/CFS are erroneous: there are over 6,000 peer-reviewed papers demonstrating the biomedical underpinnings (23).

In 2003, the “Canadian Consensus Guidelines” were published, supported by 237 references (24); in 2011 the International Consensus Criteria for ME were published (25); in 2012, two Primers for Clinicians were published (26; 27); these were all produced by the leading clinicians and scientists in the field, from 13 countries, with 400 years between them of clinical and academic experience, having authored hundreds of peer-reviewed publications and having treated about 50,000 ME patients.

Their message is unequivocal:

· ME “is characterised by an inability to produce sufficient energy on demand”; it is an acquired complex organic multi-system disease whose diagnostic feature is post-exertional exhaustion and malaise, with measurable and reproducible dysfunction of the neurological, immunological, endocrine, musculoskeletal, cardiovascular, respiratory, genitourinary and gastrointestinal systems and dysfunction of cellular energy metabolism and ion transport

· signs and symptoms include abnormalities in resting heart rate; maximum oxygen uptake; cardiac output; cerebral blood flow; respiration; cognitive functioning; gait kinetics; abnormalities of gene expression; temperature and blood pressure control and oxygen delivery to muscles, and the presence of allergies and multiple chemical sensitivity

· structural and functional neuroimaging show profound disruption in the normal coordination between the brain and the body

· special consideration is necessary for patients who are so disabled that they cannot attend a surgery or hospital, and there is need for home-based care-givers as well as support for those care-givers

· individuals meeting the 2011 International Consensus Criteria have myalgic encephalomyelitis and should be removed from the UK NICE’s own criteria for “chronic fatigue syndrome” published in 2007 (the 2003 Canadian Consensus Guidelines having been rejected for use in the UK on the Wessely School’s advice).

The distinguished authors state about Wessely’s model that there is: “much that is objectionable” about it and that it is “far from being confirmed…Nevertheless, the assumption of its truth by some has been used to influence attitudes and decisions within the medical community”. They state: “Structural and functional abnormalities within the brain and spinal cord are consistent with pathological dysfunction of the regulatory centres and communication networks of the brain, the central nervous system, and autonomic nervous system….consistent with demyelination or inflammation”.

They are clear: “The premise that cognitive therapy (eg. changing ‘illness beliefs’) and graded activity can ‘reverse’ or cure this illness is not supported by post-intervention outcome data. In routine medical practice, CBT has not yielded clinically significant outcomes for patients with ME/CFS”.

That there is profound professional concern and dismay about Wessely’s work on ME is typified by the following:

· Dr Byron Hyde, the clinician with perhaps the widest clinical experience of ME, said: “The belief that ME/CFS is a psychological illness is the error of our time” (28) and


one of the foremost AIDS and ME specialists in the world, Professor Nancy Klimas, said: I hope you are not saying that (ME)CFS patients are not as ill as HIV patients. I split my clinical time between the two illnesses, and I can tell you that if I had to choose between the two illnesses I would rather have HIV” (29).

It was in 2000 that Anthony Komaroff, Professor of Medicine at Harvard, said: “There is now considerable evidence of an underlying biological process which is inconsistent with the hypothesis that (ME/CFS) involves symptoms that are only imagined or amplified because of underlying psychiatric distress. It is time to put that hypothesis to rest” (30).

Twelve years later, Wessely is honoured for his “courage” in continuing to promote exactly that hypothesis, which is described as “standing up for sound science”.

Wessely’s work appears to be based on an ideological commitment to ME as a somatoform disorder and the recent Medical Research Council’s PACE Trial with which he was involved exemplifies serious deficiencies and is considered by many people to have no credible scientific, clinical or ethical foundation: it cannot be acceptable to describe a PACE Trial participant at the end of the trial as having attained levels of physical function and fatigue “within the normal range” and to consider the same participant sufficiently symptomatic, as judged by the same recorded levels of physical function and fatigue, to have qualified for entry into the PACE Trial in the first place.

Wessely is on record as saying about the PACE Trial: “For those who appreciate these things, the trial is a thing of
beauty” (31).

The editor of the journal Nature should be concerned about clinical trials and how they are run and reported, because this "thing of beauty" had no control group, was unblinded, and committed the cardinal sin of trial design by altering the outcome measures at the end of the trial so as to give the impression that an unsuccessful intervention favoured by the investigators was a success when in fact the results were so bad that 21 months later, no recovery rates have been (nor, it is understood, are they to be) published.

One can only assume that those awarding the prize and proffering acclaim are unaware of the scientific evidence which disproves Professor Wessely’s view about ME.

Professor Colin Blakemore, former CEO of The Medical Research Council and one of the judges, said “…the two winners stood out….Simon Wessely and Fang Shi-min have worked with courage and dignity to uphold the standards of science and evidence against the forces of prejudice and greed”.

Professor Sir John Beddington, Government Chief Scientific Advisor said: “Given the importance of science…it is more important than ever for scientists to speak up and make their views heard. This always requires conviction but often requires real courage too, and I welcome the John Maddox Prize as recognition of that”.

Sir Paul Nurse, President of The Royal Society said: “The John Maddox Prize is an exciting new initiative to recognise bold scientists who battle to ensure that sense, reason and evidence base play a role in the most contentious debates. The winners will be an inspiration to us all”.

The real problem is that the top echelons of the UK scientific community appear to have failed in their duty to the memory of John Maddox and to the innumerable patients world-wide who are suffering from ME.

That is a travesty of science, truth and justice.


Professor Malcolm Hooper and members of the ME community

15th November 2012

References
1. Myalgic Encephalomyelitis: Postviral Fatigue Syndrome: Diagnostic and Clinical Guidelines for Doctors. The ME Association, 1991

2. The Medical Research Council’s PACE Trial Identifier, section 3.9
3. The Cognitive Behavioural Management of the Post-viral Fatigue Syndrome. Simon Wessely, Sue Butler, Trudie Chalder and Anthony David. In: Post-viral Fatigue Syndrome. Ed: Rachel Jenkins and James Mowbray. John Wiley & Sons, Chichester, 1991
4. The Patient Leaflet for the PACE Trial (http://pacetrial.org/trialinfo.html)
5. Maybe it’s a virus? Beliefs about viruses, symptom attributional style and psychological health. Cope H David A Mann A. Journal of Psychosomatic Research 1994:38:2:89-98
6. Chronic fatigue syndrome: a practical guide to assessment and management. Sharpe M, Chalder T, Wessely S et al. General Hospital Psychiatry 1997:19:3:185-199)
7. Microbes, Mental Illness, The Media and ME: The Construction of Disease. Simon Wessely. 9th Eliot Slater Memorial Lecture, Institute of Psychiatry, London, 12 May 1994
8. Eradicating myalgic encephalomyelitis (ME). Simon Wessely. Report of meeting held on 15 April 1992 at Belfast Castle; Pfizer Invicta Pharmaceuticals, pp 4-5
9. Patients with medically unexplained symptoms. Alcuin Wilkie, Simon Wessely. British Journal of Hospital Medicine: 1994:51:8:421-427
10. Joint Report on Chronic Fatigue Syndrome (CR54); The Royal Colleges of Physicians, Psychiatrists and General Practitioners, 1996
11. The chronic fatigue syndrome—myalgic encephalomyelitis or postviral fatigue. S.Wessely PK Thomas. In: Recent Advances in Clinical Neurology. Ed: Christopher Kennard. Pub: Churchill Livingstone 1990 pp 85-131
12. Chronic fatigue syndrome: a practical guide to assessment and management. Sharpe M, Chalder T, Wessely S et al. General Hospital Psychiatry 1997:19:3:185-199
13. The MRC’s own summary of the CIBA Foundation Symposium on CFS that was held on 12-14th May 1992
14. In search of non-disease. British Medical Journal 2002:324:883-885
15. UNUM’s CFS Management Plan; Dr Carolyn Jackson, 4th April 1995
16. An article in 2002 by Peter Pallot on health insurance: http://www.hi-mag.com/healthinsurance/article.do?articleid=20000081634
17. Transcript of FDA Blood Products Advisory Committee, 2010: http://www.fda.gov/AdvisoryCommitte.../BloodProductsAdvisoryCommittee/ucm239304.htm
18. http://esme-eu.com/home/experts-launch-think-tank-for-mystery-disease-article37-6.html
19. Transcript of podcast with Professors Vincent Racaniello and Ian Lipkin, 18th September 2012, This Week in Virology
20. Press conference on 18th September 2012 at Columbia University: http://www.prohealth.com/library/showarticle.cfm?libid=17220
21. David Tuller, New York Times, 18th September 2012
22. www.fda.gov/downloads/Drugs/NewsEvents/UCM320310.pdf; 13th September 2012
23. “Magical Medicine: How to Make a Disease Disappear”, pages 11-13 and Section II, pages 98 – 211: http://www.meactionuk.org.uk/magical-medicine.htm
24. “Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Clinical Working Case Definition, Diagnostic and Treatment Protocols” (known as the Canadian Guidelines). BM Carruthers et al. JCFS 2003:11(1):7-115
25. The International Consensus Criteria for ME. BM Carruthers et al. Journal of Internal Medicine; 2011:270:4:327-338
26. The International Association for CFS/ME “Primer for Clinical Practitioners” (www.iacfsme.org)
27. “Myalgic Encephalomyelitis – Adult and Paediatric: International Consensus Primer for Medical Practitioners”. BM Carruthers et al: The National Library of Canada; ISBN 978-0-9739335-3-6
28. The Complexities of Diagnosis. Byron Hyde. In: handbook of Chronic Fatigue Syndrome. Ed: Leonard A. Jason et al. John Wiley & Sons Inc. 2003
29. Nancy Klimas, one of the world’s foremost AIDS and ME/CFS physicians; Professor of Medicine and Immunology, University of Miami; New York Times, 15th October 2009
30. The Biology of the Chronic Fatigue Syndrome. Anthony Komaroff. Am J Med 2000:108:99-105.
31. Health in mind and body. Simon Wessely. The Journal of the Foundation for Science and Technology, Volume 20, Number 7, December 2011 http://www.foundation.org.uk/journal/pdf/fst_20_07.pdf
 

Enid

Senior Member
Messages
3,309
Location
UK
Thanks dasimay - at last Prof Hooper's voice is heard in the press. Bit of a turning point and I saw mentioned on another thread Charles Shephard (Facebook) is currenlty doing a piece with/for the Telegraph (due out shortly) on biomedical research findings. Dare one deduce the negative press is now over.
 

Firestormm

Senior Member
Messages
5,055
Location
Cornwall England
I've been trying to read some of the comments attached to the Independent article. Can I ask a probably dumb question? Wessely was not on the PACE Trial was he? I mean he wasn't directly involved and he didn't appear on the published paper. At least not that I can recall and he is not on here:

Prof PD White MD a , KA Goldsmith MPH b, AL Johnson PhD c d, L Potts MSc b, R Walwyn MSc b, JC DeCesare BSc a, HL Baber BSc a, M Burgess PhD e, LV Clark PhD a, DL Cox PhD f, J Bavinton BSc i, BJ Angus MD g, G Murphy MSc h, M Murphy FRCP i, H O'Dowd PhD j, D Wilks FRCP[Ed] k, Prof P McCrone PhD l, Prof T Chalder PhD m *, Prof M Sharpe MD n *, on behalf of the PACE trial management group

Lancet PACE Trial Publication: http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(11)60096-2/fulltext

Also there are some comments that are quoting allegedly from the PACE CBT Model Manual - but I can't find them in that document anywhere e.g.

In their PACE Trial "Manual of cognitive-behavioural treatment for CFS"*, Professor Simon Wessely and colleagues explained that their cognitive behavioural treatment - "is based on a cognitive behavioural model of CFS".
Professor Wessely and colleagues asserted that "symptoms and disability of CFS are perpetuated predominantly by dysfunctional illness beliefs and coping behaviours" - and hence - "the patient is encouraged to think of the illness as ‘real but reversible by his or her own efforts' rather than (as many patients do) as a fixed unalterable disease".

There are other alleged quotes also that I assumed have been taken from the same manual model: e.g.

"The patient is encouraged to think of the illness as "real but reversible by his or her own efforts" rather than (as many patients do) as a fixed unalterable disease."

But the best I could come up with was e.g.:

Complex Incremental Pacing /Cognitive Behavioural Therapy (CBT)
This is the most complex treatment. It involves elements of simple pacing to stabilise
activity, graded increases in activity, as with simple incremental pacing, and also
directly addresses participant’s beliefs and fears about their symptoms and functioning.
CBT differs from GET by directly targeting cognitions and related behaviours and it
differs from APT by encouraging the participant to extend their physical functioning
beyond their current ability.

Essence
The essence of CBT is helping the participant to change their interpretation of
symptoms and associated fear, symptom focussing and avoidance. Participants are
encouraged to see symptoms as temporary and reversible and not as signs of harm or
evidence of fixed disease pathology. In this way it is anticipated that they will gain more
control of their lives, as they, and not their symptoms, dictate what they do.

Aim
The aim of this treatment is to change the behavioural and cognitive factors, which are
assumed to be partially responsible for perpetuating the participant’s symptoms and
disability, and to help the participants to develop strategies for dealing with other
factors, physical, emotional, social or financial, that may also be impacting on their
illness.

Theoretical Model
The model emphasises the importance of the participant’s understanding of their illness
and their interpretation of symptoms. For example they may interpret symptoms as a
warning sign to reduce activity. Fear of symptoms and consequent avoidance of activity
associated with symptoms is central. This model also acknowledges that the
participant’s beliefs and behaviours are influenced by available information and
attitudes of families and friends and that these may also need to be addressed. The
model assumes that physiological (fatigue), cognitive (fear of engaging in activity) and
behavioural responses (avoidance of activity), are linked. Therefore by modifying one
response it is anticipated that changes occur in the other responses. For example,
increasing activity (behaviour) may gradually reduce the fear (cognitions) that activity
leads to worsening of symptoms.

CBT PACE Model Manual: http://www.pacetrial.org/docs/cbt-therapist-manual.pdf pp12-13

PACE Trial Published in Lancet: http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(11)60096-2/fulltext

Afore anyone gets their knickers tied, I don't doubt the inherent failing of the PACE Trial itself or the abhorrent reporting that followed. Not that I should have to say this as I've said it often enough.

I just wish those who post quotes do so fairly and with a definite link to the source :)
 

Daisymay

Senior Member
Messages
754
I've been trying to read some of the comments attached to the Independent article. Can I ask a probably dumb question? Wessely was not on the PACE Trial was he? I mean he wasn't directly involved and he didn't appear on the published paper. At least not that I can recall and he is not on here:



Also there are some comments that are quoting allegedly from the PACE CBT Model Manual - but I can't find them in that document anywhere e.g.



There are other alleged quotes also that I assumed have been taken from the same manual model: e.g.



But the best I could come up with was e.g.:



CBT PACE Model Manual: http://www.pacetrial.org/docs/cbt-therapist-manual.pdf pp12-13

PACE Trial Published in Lancet: http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(11)60096-2/fulltext

Afore anyone gets their knickers tied, I don't doubt the inherent failing of the PACE Trial itself or the abhorrent reporting that followed. Not that I should have to say this as I've said it often enough.

I just wish those who post quotes do so fairly and with a definite link to the source :)
 

Daisymay

Senior Member
Messages
754
Sorry Firestorm, sent that off by mistake, brain malfunction! Wessely himself oversaw the PACE Clinical Trial Unit which was primarily responsible for design and management of the trial.
 
Messages
13,774
"symptoms and disability of CFS are perpetuated predominantly by dysfunctional illness beliefs and coping behaviours"

Just checked this, and it's in an early copy of a CBT manual for PACE, for which Wessely is one of the authors. I think that they could have used similar phrasing in the Lancet paper too. I don't know if those are on-line anywhere right now. If you want I could put them up somewhere.

edit: I had a bit of a panic, as google showed I'd posted that quote a while back without having checked it, as it was from someone I considered reliable. Only got around to checking it out just now. Here's the old thread, which I've just edited to attach the documents:

http://forums.phoenixrising.me/inde...nuals-trial-identifier-etc.15109/#post-245972

EDIT 2: Just to be clear, the quotes did check out. It sounded a bit like I was saying that I wrongly considered the person who sent them to me to be reliable, when that's not the case.

"The patient is encouraged to think of the illness as "real but reversible by his or her own efforts" rather than (as many patients do) as a fixed unalterable disease."

That one can be found by searching in this book, using Amazon's 'look inside' feature:

http://www.amazon.co.uk/Somatoform-Disorders-Experience-Psychiatry-ebook/dp/B000QCS6FS

I don't think that it's possible to link directly to either of those quotes at the moment.
 
Messages
29
Location
California
If The Daily Telegraph is working in good faith with Dr. Shepherd on a piece about biomedical research into me/cfs as Firestormm noted above, this would be a huge get for us. After all, regarding me/cfs the DT is certainly one of the more skeptical papers out there. I too will be waiting anxiously, although, given how many times we've been let down by writers whom we expected to be unbiased, I will try to manage my expectations. Fingers crossed!
 

patient.journey

Senior Member
Messages
443
one of the foremost AIDS and ME specialists in the world, Professor Nancy Klimas, said: I hope you are not saying that (ME)CFS patients are not as ill as HIV patients. I split my clinical time between the two illnesses, and I can tell you that if I had to choose between the two illnesses I would rather have HIV

I already said that a lot of times !!
 

SilverbladeTE

Senior Member
Messages
3,043
Location
Somewhere near Glasgow, Scotland
IIRC, one huge factor of this has been overlooked, one which is even more powerful against Wessely, allegedly, from what has been written, isn't he perosnally connected to/with this award/folk involved, hm?
Which is a HUGELY unethical thing if true and should have exempted him from any such award.
If true, this would be an argument: cronyism/ethics of getting an award, that would really scupper him! :thumbsup:

(isn't he on the Sense About Science committee, therefor...conflict of interest?)
 
Messages
13,774
IIRC, one huge factor of this has been overlooked, one which is even more powerful against Wessely, allegedly, from what has been written, isn't he perosnally connected to/with this award/folk involved, hm?
Which is a HUGELY unethical thing if true and should have exempted him from any such award.
If true, this would be an argument: cronyism/ethics of getting an award, that would really scupper him! :thumbsup:

(isn't he on the Sense About Science committee, therefor...conflict of interest?)

Wessely is involved with Sense About Science, but I don't think it's a big thing. If some CFS patients came up with a new award, and gave it to someone they knew, it wouldn't really matter. It's like the silly certificates kids get given, but done for adults.
 

ukxmrv

Senior Member
Messages
4,413
Location
London
PACE Trial MRC Application / Identifier:

"The trial will be run by the trial co-ordinator who will be based at Barts and the London , with the principal investigator (PI), and alongside two of the six clinical centres. He/she will liaise regularly with staff at the Clinical Trials Unit (CTU) who themselves will be primarily responsible for randomisation and database design and management (overseen by the centre statistician Dr Tony Johnson), directed by Professor Simon Wessely, in collaboration with Professor Janet Darbyshire at the MRC CTU".
 

ukxmrv

Senior Member
Messages
4,413
Location
London
File: Johnson_Wessely_job.pdf FURTHER PARTICULARS Christine Murrell Created 07/07/06


Institute of Psychiatry at The Maudsley FURTHER PARTICULARS

Statistician Clinical Trials Unit (CTU)

Division of Psychological Medicine, Ref No: 06/A09


The successful applicant will work within an established team in the Mental Health and Neurology Clinical Trials Unit (CTU), consisting of a clinical trials manager/Unit manager, two statisticians, a database programmer and a departmental administrator. The team works under the direction of Professor Simon Wessely, the Unit Director. The team is supported by the regular input of a Unit Management Group from within the Institute of Psychiatry. The statisticians within the Unit also have regular supervision meetings with Dr Tony Johnson from the MRC Clinical Trials Unit.


The post holder will be directly responsible to the CTU Manager (Caroline Murphy), supervised by the CTU Statistician (Rebecca Walwyn) and will be under the overall direction of the Head of Department, Professor Simon Wessely.